Company name
2022Founder
Riley Ennis leads product at Freenome, where he is co-founder and Chief Product Officer. The company develops blood-based tests for early cancer detection, using a multiomics platform to identify cancer signals. He has discussed clinical-trial design and Freenome’s hybrid approach to running trials.
Co-Founder and Chief Product Officer
degree in molecular biology